Lornoxicam

Generic Name
Lornoxicam
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C13H10ClN3O4S2
CAS Number
70374-39-9
Unique Ingredient Identifier
ER09126G7A
Background

Lornoxicam (chlortenoxicam) is a new nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic, anti-inflammatory and antipyretic properties. Lornoxicam differs from other oxicam compounds in its potent inhibition of prostaglandin biosynthesis, a property that explains the particularly pronounced efficacy of the drug. Lornoxicam is appro...

Indication

For the treatment of acute mild to moderate pain, as well as pain and inflammation of the joints caused by certain types of rheumatic diseases.

Associated Conditions
Osteoarthritis (OA), Rheumatoid Arthritis, Acute mild to moderate pain
Associated Therapies
-
Clinical Trials
Related News

Lornoxicam Versus Etoricoxib in Postoperative Pain After Total Knee Arthroplasty

Phase 3
Completed
Conditions
Postoperative Pain
Interventions
Drug: Lornoxicam
Drug: Etoricoxib
First Posted Date
2016-04-26
Last Posted Date
2016-04-26
Lead Sponsor
Foisor Orthopedics Clinical Hospital
Target Recruit Count
120
Registration Number
NCT02750917

Comparison Between Two Analgesic Methods for Pain Relief Following Surgical Abortion

Not Applicable
Conditions
Pain
Interventions
Drug: Paracetamol
Drug: lornoxicam
First Posted Date
2013-12-31
Last Posted Date
2013-12-31
Lead Sponsor
Rambam Health Care Campus
Target Recruit Count
82
Registration Number
NCT02025166
Locations
🇮🇱

Rambam Health Care Campus, Haifa, Israel

Lornoxicam vs. Paracetamol After Lower Abdominal Surgery

First Posted Date
2012-03-28
Last Posted Date
2012-03-28
Lead Sponsor
Imam Abdulrahman Bin Faisal University
Target Recruit Count
60
Registration Number
NCT01564680
Locations
🇸🇦

Dammam University, KFHU, Al-Khobar, EP, Saudi Arabia

Reduction of Post-operative Endodontic Pain

First Posted Date
2011-11-29
Last Posted Date
2013-01-14
Lead Sponsor
Islamic Azad University, Tehran
Target Recruit Count
60
Registration Number
NCT01480752
Locations
🇮🇷

Dental School of Azad University, Tehran, Iran, Islamic Republic of

Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease.

Phase 2
Terminated
Conditions
Alzheimer´s Disease
Interventions
Drug: Placebo
Drug: Lornoxicam
First Posted Date
2010-05-06
Last Posted Date
2013-02-06
Lead Sponsor
JSW Lifesciences
Target Recruit Count
219
Registration Number
NCT01117948

Comparative Clinical Trial of Lornoxicam to Diclofenac in Patients of Osteoarthritis of Knee Joint.

Not Applicable
Completed
Conditions
Osteoarthritis of Knee Joint
Interventions
Drug: Lornoxicam
Drug: Diclofenac
First Posted Date
2010-01-25
Last Posted Date
2010-01-25
Lead Sponsor
Government Medical College, Bhavnagar
Target Recruit Count
40
Registration Number
NCT01055470
Locations
🇮🇳

Sir Takthasinhji General Hospital, Bhavnagar, Gujarat, India

Efficacy and Safety of Lornoxicam in Patients With Acute Coronary Syndrome

Phase 4
Completed
Conditions
Acute Coronary Syndrome
Interventions
Drug: Lornoxicam
First Posted Date
2009-10-19
Last Posted Date
2009-10-19
Lead Sponsor
Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation
Target Recruit Count
85
Registration Number
NCT00997750
Locations
🇷🇺

Central Clinical Hospital of Presidential Department Of Russian Federation, Moscow, Russian Federation

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy